PAR-25-096-Full-Announcement.html

This document is a Notice of Funding Opportunity (NOFO) for the federal grant opportunity titled "Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)". The NOFO is being issued by the National Cancer Institute (NCI) and other participating Institutes under the Department of Health and Human Services National Institutes of Health.

The grant opportunity encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources to elucidate cancer risk and related outcomes such as risk prediction or reduction, survival, or response to treatment. Eligible applicant types include small businesses, non-profits, government entities, and higher education institutions. The funding activity categories are education and health. The NOFO is associated with four federal grant programs: Cancer Cause and Prevention Research, Oral Diseases and Disorders Research, Human Genome Research, and Aging Research.